Amid Tough Market Conditions, Bruker and CombiMatrix Stocks Had Strong February | GenomeWeb
NEW YORK (GenomeWeb News) – Shares of Bruker and CombiMatrix were among the best performers in February among the stocks tracked by GenomeWeb Daily News (see below), as they bucked a downward trend in the general stock market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.